EntryPoint Capital »

Biosante Pharmaceuticals shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $174k 2.7k 63.68

More positions owned by EntryPoint Capital

Global Ship Lease Com Cl A (GSL)
Delek Us Holdings (DK)
CoStar (CSGP)
Vista Energy S.a.b. De C.v. Sponsored Ads (VIST)
Skechers U S A Cl A (SKX)
Nextera Energy Partners Com Unit Part In (NEP)
Alerus Finl (ALRS)
Liveramp Holdings (RAMP)
Trimas Corp Com New (TRS)
Cbl & Assoc Pptys Common Stock (CBL)
Rockwell Automation (ROK)
Illinois Tool Works (ITW)
National Fuel Gas (NFG)
EastGroup Properties (EGP)
Hologic (HOLX)

View all positions for EntryPoint Capital

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
State Street Corporation
Rubric Capital Management
Ranger Investment Management
Pacer Advisors
Jpmorgan Chase & Co
Global Alpha Capital Management
William Blair Investment Management
Deep Track Capital
Tang Capital Management
Geode Capital Management
Citadel Advisors
Macquarie Group

View all funds holding Biosante Pharmaceuticals